Nontuberculous Mycobacterial Pulmonary Infections in Non-HIV Patients

References

• Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest. 2006; 129(6): 1653–1672.
   PubMed Web of Science ®Google Scholar
• Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol. 2008; 61(9): 1006–1012.
   Google Scholar
• Martinez S, McAdams HP, Batchu CS. The many faces of pulmonary nontuberculous mycobacterial infections. AJR Am J Roentgenol. 2007; 189(1): 177–186.
   Web of Science ®Google Scholar
• Falkinham JO. The changing pattern of nontuberculous mycobacterial disease. Can J Infect Dis. 2003; 14(5): 281–286.
   Google Scholar
• Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev. 2003; 16(2): 319–354.
   PubMed Web of Science ®Google Scholar
• Runyan EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am. 1959; 43(1): 273–290.
   Google Scholar
• De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006; 42(12): 1756–1763.
   PubMed Web of Science ®Google Scholar
• Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002; 23(3): 529–551.
   Google Scholar
• Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008; 133(1): 243–251.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4): 367–416.
   PubMed Web of Science ®Google Scholar
• Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis. 1982; 146(6): 829–833.
   Google Scholar
• Butler WR, Crawford JT. Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories United States 1993–1996. Published July 1999. http://www.cdc.gov/tb/Laboratory_Services/NontuberculousMycobacteria.pdf. Accessed August 12, 2008.
   Google Scholar
• Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med. 2007; 176(3): 306–313.
   Google Scholar
• Falkinham JO 3rd, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other mycobacteria in drinking water distribution systems. Appl Environ Microbiol. 2001; 67(3): 1225–1231.
   PubMed Web of Science ®Google Scholar
• McGarvey J, Bermudez LE. Pathogenesis of nontuberculous mycobacteria infections. Clin Chest Med. 2002; 23(3): 569–583.
   Google Scholar
• Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev. 2005; 203: 38–47.
   PubMed Web of Science ®Google Scholar
• Koh WJ, Kwan OJ, Kim EJ, Lee KS, Ki CS, Kim JW. NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung disease. Chest. 2005; 128(1): 94–101.
   Google Scholar
• Erasmus JJ, McAdams HP, Farrell MA, et al. Pulmonary nontuberculous mycobacterial infection: radiologic manifestations. Radiographics. 1999; 19(6): 1487–1505.
   Google Scholar
• Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine (Baltimore). 1994; 73(2): 103–109.
   PubMedGoogle Scholar
• Wickremasinghe M, Ozerovitch LJ, Davies G, et al. Nontuberculous mycobacteria in patients with bronchiectasis. Thorax. 2005; 60(12): 1045–1051.
   PubMed Web of Science ®Google Scholar
• Olivier KN; NTM in CF Study Group. The natural history of nontuberculous mycobacteria in patients with cystic fibrosis. Paediatr Respir Rev. 2004; 5(suppl A): S213–S216.
   Google Scholar
• Hadjiliadis D, Adlakha A, Prakash UB. Rapidly growing mycobacterial lung infection in association with esophageal disorders. Mayo Clin Proc. 1999; 74(1): 45–51.
   Google Scholar
• Koh WJ, Lee JH, Kwon YS, et al. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest. 2007; 131(6): 1825–1830.
   PubMed Web of Science ®Google Scholar
• Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis. 1991; 144(4): 914–916.
   Google Scholar
• Fowler SJ, French J, Screaton NJ, et al. Nontuberulous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J. 2006; 28(6): 1204–1210.
   PubMed Web of Science ®Google Scholar
• Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Resp J. 2006; 28(2): 352–357.
   Google Scholar
• Hayes D Jr. Mycobacteria abscessus and other nontuberculous mycobacteria: evolving respiratory pathogens in cystic fibrosis: a case report and review. South Med J. 2005; 98(6): 657–661.
   Google Scholar
• Olivier KN, Weber DJ, Wallace RJ Jr, et al. Nontuberculous mycobacteria I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003; 167(6): 828–834.
   PubMed Web of Science ®Google Scholar
• Levy I, Grisaru-Soen G, Lerner-Geva L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis. 2008; 14(3): 378–384.
   PubMed Web of Science ®Google Scholar
• Reich JM, Johnson RE. Mycobacterial avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest. 1992; 101(6): 1605–1609.
   PubMed Web of Science ®Google Scholar
• Leite CQ, da Silva Rocha A, de Andrade Leite SR, et al. A comparison of mycolic acid analysis for nontuberculous mycobacteria identification by thin-layer chromatography and molecular methods. Microbiol Immunol. 2005; 49(7): 571–578.
   Google Scholar
• Kitada S, Kobayashi K, Ichiyama S, et al. Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med. 2008; 177(7): 793–797.
   PubMed Web of Science ®Google Scholar
• Research Committee of the British Thoracic Society. First randomized trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax. 2001; 56(3): 167–172.
   Google Scholar
• Shitrit D, Baum GL, Priess R, et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999–2004: clinical features, drug susceptibility, and outcome. Chest. 2006; 129(3): 771–776.
   PubMed Web of Science ®Google Scholar
• van Ingen J, Boeree MJ, de Lange WC, et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis. 2008; 14(3): 385–389.
   Web of Science ®Google Scholar
• Milanés-Virelles MT, García-García I, Santos-Herrera Y, et al. Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study. BMC Infect Dis. 2008; 8: 17.
   PubMedGoogle Scholar
• Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi M. Pneumonectomy for nontuberculous mycobacterial infections. Ann Thorac Surg. 2004; 78(2): 399–403.
   Google Scholar
• Watanabe M, Hasegawa N, Ishizaka A, et al. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. Ann Thorac Surg. 2006; 81(6): 2026–2030.
   Google Scholar